Article
Study Finds Low-Dose Aspirin Can Reduce the Risk of Pancreatic Cancer
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in
, a journal of the American Association for Cancer Research.
Cancer Epidemiology, Biomarkers & Prevention
“We found that the use of low-dose aspirin was associated with cutting the risk of pancreatic cancer in half, with some evidence that the longer low-dose aspirin was used, the lower the risk,” said
, professor of epidemiology in the Department of Chronic Disease Epidemiology at the
and Yale Cancer Center in New Haven, Connecticut. “Because about one in 60 adults will get pancreatic cancer and the five-year survival rate is less than 5 percent, it is crucial to find ways to prevent this disease.”
Harvey A. Risch, MD, PhDYale School of Public Health
Men and women who took low-dose aspirin regularly had 48 percent reduction in their risk for developing pancreatic cancer. Protection against pancreatic cancer ranged from 39 percent reduction in risk for those who took low-dose aspirin for six years or less, to 60 percent reduction in risk for those who took low-dose aspirin for more than 10 years.
Press release:
Source: AACR
